Efficacy of inhaled prostanoids in experimental pulmonary hypertension

Critical Care Medicine

Volumn 26, Issue 6, 1998, Pages 1103-1109

  Kleen, Martin ^a,b   Habler, Oliver ^a,b   Hofstetter, Christian ^a   Pusch, Rainer ^a,b   Mueller, Markus ^c   Welte, Martin ^a,b   Zwissler, Bernhard ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acute respiratory distress syndrome; Circulation; Inhalation therapy; PGE1; Pressure volume relationship; Prostacyclin; Prostanoid pharmacology; Pulmonary; Pulmonary hypertension; Sheep; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; PROSTACYCLIN; PROSTAGLANDIN E1; PROSTANOID; THROMBOXANE A2;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG VASOCONSTRICTION; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SHEEP;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADMINISTRATION, INHALATION; ALPROSTADIL; ANIMALS; EPOPROSTENOL; FEMALE; HEMODYNAMIC PROCESSES; HYPERTENSION, PULMONARY; INFUSIONS, INTRAVENOUS; MALE; SHEEP; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0031777540     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199806000-00036     Document Type: Article

References (34)

1. Sibbald WJ, Driedger AA, Short AI, Wells GA: Biventricular function in the adult respiratory distress syndrome. Chest 1983; 84:126-134
2. Radermacher P, Santak B: Vasodilating agents in ARDS. In: Update in Intensive Care and Emergency Medicine. Vincent JL (Ed). Berlin, Heidelberg, New York, Springer Verlag, 1991, pp 307-309
3. 1 in man. J Clin Invest 1975; 56:1404-1410
4. Piper PJ, Vane JR, Wyllie JH: Inactivation of prostaglandins by the lungs. Nature 1970; 225:600-604
5. 1 study group. Chest 1990; 98:405-410
6. 1 during continuous intravenous infusion in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1988; 137: 5-12
7. 2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 1993; 25:329-340
8. Zwissler B, Welte M, Habler O, et al: Effects of inhaled prostacyclin as compared with inhaled nitric oxide in a canine model of pulmonary microembolism and oleic acid edema. J Cardiothorac Vasc Anesth 1995; 9: 634-640
9. 2) versus inhaled nitric oxide (NO) in adult respiratory distress syndrome (ARDS). J Respir Crit Care Med 1996; 154: 1671-1677
10. Zwissler B, Rank N, Jaenicke U, et al: Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology 1995; 82:1512-1516
11. Pappert D, Busch T, Gerlach H, et al: Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 1995; 82:1507-1511
12. Walmrath D, Schneider T, Pilch J, et al: Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 1993; 342:961-962
13. 2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs. Intensive Care Med 1996; 22:426-433
14. 2) in healthy lambs: Effects of tracheal, bronchial and alveolar morphology. Intensive Care Med 1996; 22: 1232-1238
15. 1) in combination with nitric oxide (NO) for the treatment of pulmonary hypertension - A new strategy in thoracic organ transplantation? Langenbecks Arch Chir 1996; Suppl 1:285-290
16. Prielipp RC, Rosenthal MH, Pearl RG: Vasodilator therapy in vasoconstrictor-induced pulmonary hypertension in sheep. Anesthesiology 1988; 68: 552-558
17. 1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep. Anesth Analg 1988; 67:722-729
18. Leeman M, Lejeune P, Melot C, et al: Pulmonary vascular pressure-flow plots in canine oleic acid pulmonary edema. Am Rev Respir Dis 1988; 138: 362-367
19. Nunn JF: Nunn's Applied Respiratory Physiology. Fourth Edition. Oxford, Butterworth Heinemann, 1993
20. 2 mediates hemodynamic and respiratory dysfunction in graded bacteremia. Surgery 1986; 100:214-221
21. Malik AB: Pulmonary microembolism. Physiol Rev 1983; 63:1114-1207
22. Weite M, Zwissler B, Kleen M, et al: Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vaso-constriction induced by thromboxane analogue in dogs. Acta Physiol Scand 1995; 154:395-405
23. Lodato RF, Michael JR, Murray PA: Multipoint pulmonary vascular pressure-cardiac output plots in conscious dogs. Am J Physiol 1985; 249: H351-H357
24. Graham R, Skoog C, Oppenheimer L, et al: Critical closure in the canine pulmonary vasculature. Circ Res 1982; 50:566-572
25. Ewalenko P, Stefanidis C, Holoye A, et al: Pulmonary vascular impedance vs. resistance in hypoxic and hyperoxic dogs: Effects of propofol and isoflurane. J Appl Physiol 1993; 74:2188-2193
26. Jasper AC, Soohoo SL, Goldberg HS: Relationship of arterial wedge pressure to closing pressure in the pulmonary circulation. Am Rev Respir Dis 1986; 134:879-884
27. 1 and hydralazine on the longitudinal distribution of pulmonary vascular resistance during vasoconstrictor pulmonary hypertension in sheep. Anesthesiology 1992; 76:106-112
28. 2. J Pharmacol Exp Ther 1980; 214:68-73
29. Keirse MJ, Hicks BR: Comparison of intrauterine prostaglandin metabolism during pregnancy in man, sheep and guinea pig. Eur J Obstet Gynecol Reprod Biol 1978; 8:195-203
30. Katzen DR, Pong SS, Levine L: Distribution of prostaglandin E 9-ketoreductase and NAD+-dependent and NADP+-dependent 15-hydroxyprostaglandin dehydrogenase in the renal cortex and medulla of various species. Res Commun Chem Pathol Pharmacol 1975; 12:781-787
31. 1. Eur Respir J 1988; 1:711-715
32. Delcroix M, Melot C, Lejeune P, et al: Effects of vasodilators on gas exchange in acute canine embolic pulmonary hyertension. Anesthesiology 1990; 72: 77-84
33. 1 in unanesthetized sheep. Microcirc Endothelium Lymphatics 1984; 1:307-327
34. Olschewski H, Walmrath D, Schermuly R, et al: Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 1996; 124: 820-824